25 XP   0   0   10

Whanin Pharm
Buy, Hold or Sell?

Let's analyse Whanin together

PenkeI guess you are interested in Whanin Pharm. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Whanin Pharm. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Whanin Pharm

I send you an email if I find something interesting about Whanin Pharm.

Quick analysis of Whanin (30 sec.)










What can you expect buying and holding a share of Whanin? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
₩23,462.71
Expected worth in 1 year
₩25,053.01
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₩1,590.31
Return On Investment
11.5%

For what price can you sell your share?

Current Price per Share
₩13,810.00
Expected price per share
₩12,410 - ₩14,240
How sure are you?
50%

1. Valuation of Whanin (5 min.)




Live pricePrice per Share (EOD)

₩13,810.00

Intrinsic Value Per Share

₩13,589.32 - ₩16,649.10

Total Value Per Share

₩37,052.02 - ₩40,111.81

2. Growth of Whanin (5 min.)




Is Whanin growing?

Current yearPrevious yearGrowGrow %
How rich?$250.7m$228.5m$14.6m6.0%

How much money is Whanin making?

Current yearPrevious yearGrowGrow %
Making money$5.2m$4.1m$1m19.7%
Net Profit Margin12.9%12.1%--

How much money comes from the company's main activities?

3. Financial Health of Whanin (5 min.)




What can you expect buying and holding a share of Whanin? (5 min.)

Welcome investor! Whanin's management wants to use your money to grow the business. In return you get a share of Whanin.

What can you expect buying and holding a share of Whanin?

First you should know what it really means to hold a share of Whanin. And how you can make/lose money.

Speculation

The Price per Share of Whanin is ₩13,810. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Whanin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Whanin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩23,462.71. Based on the TTM, the Book Value Change Per Share is ₩397.58 per quarter. Based on the YOY, the Book Value Change Per Share is ₩273.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Whanin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.350.0%0.340.0%0.270.0%0.280.0%0.280.0%
Usd Book Value Change Per Share0.350.0%0.280.0%0.190.0%0.430.0%0.430.0%
Usd Dividend Per Share0.000.0%0.000.0%0.100.0%0.130.0%0.130.0%
Usd Total Gains Per Share0.350.0%0.280.0%0.300.0%0.560.0%0.560.0%
Usd Price Per Share10.53-10.50-12.01-11.67-11.67-
Price to Earnings Ratio7.59-7.78-11.39-11.55-11.55-
Price-to-Total Gains Ratio29.77-45.43-43.21-38.10-38.10-
Price to Book Ratio0.64-0.66-0.80-0.84-0.84-
Price-to-Total Gains Ratio29.77-45.43-43.21-38.10-38.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.667
Number of shares103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.13
Usd Book Value Change Per Share0.280.43
Usd Total Gains Per Share0.280.56
Gains per Quarter (103 shares)28.6757.60
Gains per Year (103 shares)114.66230.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011510552178220
20229220104357450
30344335156535680
40459450208714910
505735652608921140
6068868031110711370
7080379536312491600
8091791041514281830
901032102546716062060
1001147114051917852290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%24.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%19.01.00.095.0%22.02.00.091.7%
Dividend per Share0.00.04.00.0%6.00.06.050.0%12.00.08.060.0%12.00.08.060.0%15.00.09.062.5%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%24.00.00.0100.0%

Fundamentals of Whanin

About Whanin Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 01:02:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Whanin Pharm.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Whanin earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.0% means that ₩0.13 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Whanin Pharm:

  • The MRQ is 13.0%. The company is making a huge profit. +2
  • The TTM is 12.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.0%TTM12.9%+0.0%
TTM12.9%YOY12.1%+0.9%
TTM12.9%5Y13.1%-0.1%
5Y13.1%10Y13.1%0.0%
1.1.2. Return on Assets

Shows how efficient Whanin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.9% Return on Assets means that Whanin generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Whanin Pharm:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM1.9%0.0%
TTM1.9%YOY1.7%+0.2%
TTM1.9%5Y1.8%+0.1%
5Y1.8%10Y1.8%0.0%
1.1.3. Return on Equity

Shows how efficient Whanin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.1% Return on Equity means Whanin generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Whanin Pharm:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%0.0%
TTM2.1%YOY1.8%+0.3%
TTM2.1%5Y2.0%+0.2%
5Y2.0%10Y2.0%0.0%

1.2. Operating Efficiency of Whanin Pharm.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Whanin is operating .

  • Measures how much profit Whanin makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Whanin Pharm:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY15.0%-15.0%
TTM-5Y14.1%-14.1%
5Y14.1%10Y14.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Whanin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are ₩1.48 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Whanin Pharm:

  • The MRQ is 1.482. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.439. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.482TTM1.439+0.043
TTM1.439YOY1.352+0.086
TTM1.4395Y1.352+0.087
5Y1.35210Y1.3520.000

1.3. Liquidity of Whanin Pharm.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Whanin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.30 means the company has ₩5.30 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Whanin Pharm:

  • The MRQ is 5.299. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.380. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.299TTM5.380-0.081
TTM5.380YOY6.814-1.434
TTM5.3805Y7.339-1.959
5Y7.33910Y7.3390.000
1.3.2. Quick Ratio

Measures if Whanin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.69 means the company can pay off ₩2.69 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Whanin Pharm:

  • The MRQ is 2.689. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.630. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.689TTM2.630+0.058
TTM2.630YOY4.019-1.388
TTM2.6305Y4.675-2.044
5Y4.67510Y4.6750.000

1.4. Solvency of Whanin Pharm.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Whanin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Whanin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.11 means that Whanin assets are financed with 10.7% credit (debt) and the remaining percentage (100% - 10.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Whanin Pharm:

  • The MRQ is 0.107. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.109. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.107TTM0.109-0.002
TTM0.109YOY0.089+0.020
TTM0.1095Y0.100+0.010
5Y0.10010Y0.1000.000
1.4.2. Debt to Equity Ratio

Measures if Whanin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 12.0% means that company has ₩0.12 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Whanin Pharm:

  • The MRQ is 0.120. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.123. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.120TTM0.123-0.003
TTM0.123YOY0.098+0.025
TTM0.1235Y0.111+0.012
5Y0.11110Y0.1110.000

2. Market Valuation of Whanin Pharm

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Whanin generates.

  • Above 15 is considered overpriced but always compare Whanin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 7.59 means the investor is paying ₩7.59 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Whanin Pharm:

  • The EOD is 6.966. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.586. Based on the earnings, the company is underpriced. +1
  • The TTM is 7.783. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.966MRQ7.586-0.620
MRQ7.586TTM7.783-0.197
TTM7.783YOY11.389-3.605
TTM7.7835Y11.555-3.771
5Y11.55510Y11.5550.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Whanin Pharm:

  • The EOD is 15.794. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.200. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -11.945. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.794MRQ17.200-1.407
MRQ17.200TTM-11.945+29.145
TTM-11.945YOY-340.203+328.257
TTM-11.9455Y-67.084+55.138
5Y-67.08410Y-67.0840.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Whanin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.64 means the investor is paying ₩0.64 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Whanin Pharm:

  • The EOD is 0.589. Based on the equity, the company is cheap. +2
  • The MRQ is 0.641. Based on the equity, the company is cheap. +2
  • The TTM is 0.660. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.589MRQ0.641-0.052
MRQ0.641TTM0.660-0.019
TTM0.660YOY0.802-0.142
TTM0.6605Y0.836-0.176
5Y0.83610Y0.8360.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Whanin Pharm compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--505.128397.576+27%273.504+85%618.917-18%618.917-18%
Book Value Per Share--23462.70622761.966+3%21387.104+10%20148.726+16%20148.726+16%
Current Ratio--5.2995.380-2%6.814-22%7.339-28%7.339-28%
Debt To Asset Ratio--0.1070.109-2%0.089+21%0.100+8%0.100+8%
Debt To Equity Ratio--0.1200.123-2%0.098+23%0.111+8%0.111+8%
Dividend Per Share----0%150.000-100%180.000-100%180.000-100%
Eps--495.651487.557+2%391.714+27%400.990+24%400.990+24%
Free Cash Flow Per Share--218.601-135.786+162%-833.619+481%24.899+778%24.899+778%
Free Cash Flow To Equity Per Share--218.601-137.224+163%-917.625+520%-43.098+120%-43.098+120%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16649.101--------
Intrinsic Value_10Y_min--13589.316--------
Intrinsic Value_1Y_max---293.781--------
Intrinsic Value_1Y_min---289.718--------
Intrinsic Value_3Y_max--612.683--------
Intrinsic Value_3Y_min--554.729--------
Intrinsic Value_5Y_max--3321.985--------
Intrinsic Value_5Y_min--2954.676--------
Market Cap210838651000.000-9%229617184000.000228968332250.000+0%261830765000.000-12%254609426700.000-10%254609426700.000-10%
Net Profit Margin--0.1300.129+0%0.121+7%0.131-1%0.131-1%
Operating Margin----0%0.150-100%0.141-100%0.141-100%
Operating Ratio--1.4821.439+3%1.352+10%1.352+10%1.352+10%
Pb Ratio0.589-9%0.6410.660-3%0.802-20%0.836-23%0.836-23%
Pe Ratio6.966-9%7.5867.783-3%11.389-33%11.555-34%11.555-34%
Price Per Share13810.000-9%15040.00014997.500+0%17150.000-12%16677.000-10%16677.000-10%
Price To Free Cash Flow Ratio15.794-9%17.200-11.945+169%-340.203+2078%-67.084+490%-67.084+490%
Price To Total Gains Ratio27.340-9%29.77545.427-34%43.205-31%38.100-22%38.100-22%
Quick Ratio--2.6892.630+2%4.019-33%4.675-42%4.675-42%
Return On Assets--0.0190.019-1%0.017+13%0.018+5%0.018+5%
Return On Equity--0.0210.021-1%0.018+15%0.020+6%0.020+6%
Total Gains Per Share--505.128397.576+27%423.504+19%798.916-37%798.916-37%
Usd Book Value--250745236.413243256449.009+3%228563342.345+10%215328833.567+16%215328833.567+16%
Usd Book Value Change Per Share--0.3540.278+27%0.191+85%0.433-18%0.433-18%
Usd Book Value Per Share--16.42415.933+3%14.971+10%14.104+16%14.104+16%
Usd Dividend Per Share----0%0.105-100%0.126-100%0.126-100%
Usd Eps--0.3470.341+2%0.274+27%0.281+24%0.281+24%
Usd Free Cash Flow--2336183.346-1451138.523+162%-8908865.663+481%266097.206+778%266097.206+778%
Usd Free Cash Flow Per Share--0.153-0.095+162%-0.584+481%0.017+778%0.017+778%
Usd Free Cash Flow To Equity Per Share--0.153-0.096+163%-0.642+520%-0.030+120%-0.030+120%
Usd Market Cap147587055.700-9%160732028.800160277832.575+0%183281535.500-12%178226598.690-10%178226598.690-10%
Usd Price Per Share9.667-9%10.52810.498+0%12.005-12%11.674-10%11.674-10%
Usd Profit--5297003.5235210506.376+2%4186236.444+27%4285365.470+24%4285365.470+24%
Usd Revenue--40870193.22440318876.322+1%34813578.520+17%32829523.680+24%32829523.680+24%
Usd Total Gains Per Share--0.3540.278+27%0.296+19%0.559-37%0.559-37%
 EOD+4 -4MRQTTM+25 -7YOY+22 -135Y+17 -1810Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Whanin Pharm based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.966
Price to Book Ratio (EOD)Between0-10.589
Net Profit Margin (MRQ)Greater than00.130
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.689
Current Ratio (MRQ)Greater than15.299
Debt to Asset Ratio (MRQ)Less than10.107
Debt to Equity Ratio (MRQ)Less than10.120
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.019
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Whanin Pharm based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.624
Ma 20Greater thanMa 5014,189.500
Ma 50Greater thanMa 10014,468.600
Ma 100Greater thanMa 20014,574.500
OpenGreater thanClose13,800.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  941,286989,3911,930,677-1,262,265668,4121,084,6881,753,100-2,086,298-333,198



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets401,226,633
Total Liabilities43,019,153
Total Stockholder Equity358,207,481
 As reported
Total Liabilities 43,019,153
Total Stockholder Equity+ 358,207,481
Total Assets = 401,226,633

Assets

Total Assets401,226,633
Total Current Assets212,101,332
Long-term Assets189,125,301
Total Current Assets
Cash And Cash Equivalents 45,366,210
Short-term Investments 33,090,812
Net Receivables 74,525,540
Inventory 54,057,947
Other Current Assets 0
Total Current Assets  (as reported)212,101,332
Total Current Assets  (calculated)207,040,509
+/- 5,060,824
Long-term Assets
Property Plant Equipment 131,210,939
Intangible Assets 5,381,754
Long-term Assets Other 0
Long-term Assets  (as reported)189,125,301
Long-term Assets  (calculated)136,592,694
+/- 52,532,607

Liabilities & Shareholders' Equity

Total Current Liabilities40,027,751
Long-term Liabilities2,991,402
Total Stockholder Equity358,207,481
Total Current Liabilities
Accounts payable 18,071,434
Other Current Liabilities 2,611,273
Total Current Liabilities  (as reported)40,027,751
Total Current Liabilities  (calculated)20,682,707
+/- 19,345,043
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt632,025
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)2,991,402
Long-term Liabilities  (calculated)632,026
+/- 2,359,376
Total Stockholder Equity
Retained Earnings 339,984,187
Total Stockholder Equity (as reported)358,207,481
Total Stockholder Equity (calculated)339,984,187
+/- 18,223,293
Other
Capital Stock9,700,035
Common Stock Shares Outstanding 15,267
Net Invested Capital 358,207,481
Net Working Capital 172,073,582
Property Plant and Equipment Gross 165,390,809



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
181,428,238
183,952,287
182,029,881
185,659,411
300,272,097
294,955,829
299,588,019
304,884,815
306,908,256
309,668,860
321,770,917
329,559,588
334,318,970
339,287,810
344,806,859
353,188,872
355,081,536
350,635,025
358,602,680
369,374,561
382,343,031
386,399,908
390,699,295
401,226,633
401,226,633390,699,295386,399,908382,343,031369,374,561358,602,680350,635,025355,081,536353,188,872344,806,859339,287,810334,318,970329,559,588321,770,917309,668,860306,908,256304,884,815299,588,019294,955,829300,272,097185,659,411182,029,881183,952,287181,428,238
   > Total Current Assets 
131,470,887
134,095,838
132,103,357
135,833,183
198,907,088
192,920,218
197,338,731
204,976,600
210,831,615
209,967,037
220,172,528
214,354,888
221,096,002
224,075,593
231,050,295
242,411,930
198,396,724
186,009,227
193,945,269
197,421,515
206,496,761
206,873,150
210,109,409
212,101,332
212,101,332210,109,409206,873,150206,496,761197,421,515193,945,269186,009,227198,396,724242,411,930231,050,295224,075,593221,096,002214,354,888220,172,528209,967,037210,831,615204,976,600197,338,731192,920,218198,907,088135,833,183132,103,357134,095,838131,470,887
       Cash And Cash Equivalents 
50,822,628
42,794,579
33,821,028
38,940,989
44,800,623
40,533,558
27,796,625
17,981,909
18,299,576
33,965,835
47,687,082
36,074,053
42,240,785
40,405,560
41,233,193
64,055,897
55,639,015
39,585,520
41,090,132
36,775,699
40,527,697
61,217,742
53,077,247
45,366,210
45,366,21053,077,24761,217,74240,527,69736,775,69941,090,13239,585,52055,639,01564,055,89741,233,19340,405,56042,240,78536,074,05347,687,08233,965,83518,299,57617,981,90927,796,62540,533,55844,800,62338,940,98933,821,02842,794,57950,822,628
       Short-term Investments 
18,781,265
30,133,706
33,878,314
32,100,439
56,816,998
52,974,492
73,839,732
93,897,098
101,714,726
83,449,445
77,715,848
80,881,964
81,687,980
84,810,595
93,694,302
81,905,918
39,203,586
43,719,139
48,232,045
50,516,212
45,957,589
17,735,890
21,730,304
33,090,812
33,090,81221,730,30417,735,89045,957,58950,516,21248,232,04543,719,13939,203,58681,905,91893,694,30284,810,59581,687,98080,881,96477,715,84883,449,445101,714,72693,897,09873,839,73252,974,49256,816,99832,100,43933,878,31430,133,70618,781,265
       Net Receivables 
47,335,863
46,060,531
45,715,034
44,799,948
67,896,813
68,332,434
65,139,387
64,554,761
63,597,342
64,369,135
67,770,951
64,105,735
66,138,337
65,635,047
64,490,568
63,200,879
68,033,048
67,362,603
67,910,614
72,326,106
69,352,416
70,754,650
77,015,559
74,525,540
74,525,54077,015,55970,754,65069,352,41672,326,10667,910,61467,362,60368,033,04863,200,87964,490,56865,635,04766,138,33764,105,73567,770,95164,369,13563,597,34264,554,76165,139,38768,332,43467,896,81344,799,94845,715,03446,060,53147,335,863
       Inventory 
14,438,005
13,642,173
14,457,786
15,772,356
26,057,940
27,816,509
27,370,460
28,217,872
26,732,816
27,821,180
26,728,134
32,764,471
30,319,923
32,422,959
31,097,929
32,745,129
34,806,691
34,637,510
35,761,308
37,059,693
42,989,573
49,205,625
50,938,853
54,057,947
54,057,94750,938,85349,205,62542,989,57337,059,69335,761,30834,637,51034,806,69132,745,12931,097,92932,422,95930,319,92332,764,47126,728,13427,821,18026,732,81628,217,87227,370,46027,816,50926,057,94015,772,35614,457,78613,642,17314,438,005
       Other Current Assets 
93,126
1,464,849
4,231,195
4,219,451
103,442
0
0
275,510
254,324
148,448
116,442
343,611
406,426
378,890
176,660
169,720
124,064
149,547
393,258
317,022
1
-1
0
0
00-11317,022393,258149,547124,064169,720176,660378,890406,426343,611116,442148,448254,324275,51000103,4424,219,4514,231,1951,464,84993,126
   > Long-term Assets 
0
0
0
0
101,365,009
102,035,610
102,249,288
99,908,215
96,076,641
99,701,823
101,598,389
115,204,701
113,222,968
115,212,217
113,756,563
110,776,942
156,684,812
164,625,798
164,657,411
171,953,047
175,846,269
179,526,758
180,589,886
189,125,301
189,125,301180,589,886179,526,758175,846,269171,953,047164,657,411164,625,798156,684,812110,776,942113,756,563115,212,217113,222,968115,204,701101,598,38999,701,82396,076,64199,908,215102,249,288102,035,610101,365,0090000
       Property Plant Equipment 
38,078,134
37,923,409
37,996,954
37,908,194
40,054,917
40,709,784
40,357,258
39,697,041
39,706,986
40,454,119
40,320,005
45,822,031
45,820,676
47,035,100
47,402,669
46,869,086
90,414,037
104,164,741
104,908,436
109,853,912
113,363,118
118,166,251
122,938,453
131,210,939
131,210,939122,938,453118,166,251113,363,118109,853,912104,908,436104,164,74190,414,03746,869,08647,402,66947,035,10045,820,67645,822,03140,320,00540,454,11939,706,98639,697,04140,357,25840,709,78440,054,91737,908,19437,996,95437,923,40938,078,134
       Goodwill 
0
0
0
0
714,491
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000714,4910000
       Long Term Investments 
5,000,000
5,000,000
5,000,000
5,000,000
21,761,292
21,866,854
22,623,046
21,213,717
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000021,213,71722,623,04621,866,85421,761,2925,000,0005,000,0005,000,0005,000,000
       Intangible Assets 
4,670,175
4,673,135
4,623,465
4,580,914
2,426,602
3,247,647
3,187,960
3,114,736
3,079,610
2,911,004
3,055,911
2,987,632
2,923,076
3,059,399
3,000,737
2,969,117
2,874,704
2,821,773
3,135,852
3,176,129
3,130,371
3,219,908
3,579,840
5,381,754
5,381,7543,579,8403,219,9083,130,3713,176,1293,135,8522,821,7732,874,7042,969,1173,000,7373,059,3992,923,0762,987,6323,055,9112,911,0043,079,6103,114,7363,187,9603,247,6472,426,6024,580,9144,623,4654,673,1354,670,175
       Long-term Assets Other 
0
0
0
0
530,604
0
0
99,908,215
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000099,908,21500530,6040000
> Total Liabilities 
18,898,537
23,467,915
17,278,262
16,433,216
36,823,251
28,659,526
28,252,439
30,423,660
33,464,129
29,182,772
32,327,851
32,957,381
33,856,657
30,936,295
30,224,451
35,963,186
34,109,904
27,094,681
30,966,540
35,446,436
45,557,641
41,851,572
40,203,649
43,019,153
43,019,15340,203,64941,851,57245,557,64135,446,43630,966,54027,094,68134,109,90435,963,18630,224,45130,936,29533,856,65732,957,38132,327,85129,182,77233,464,12930,423,66028,252,43928,659,52636,823,25116,433,21617,278,26223,467,91518,898,537
   > Total Current Liabilities 
13,470,033
18,031,434
11,884,006
10,974,791
32,250,267
22,906,407
22,853,298
24,743,296
28,449,275
23,991,586
26,645,822
26,724,884
27,864,809
25,168,084
24,654,311
30,900,267
30,488,568
24,348,081
28,145,325
31,750,480
41,623,077
38,053,188
36,076,099
40,027,751
40,027,75136,076,09938,053,18841,623,07731,750,48028,145,32524,348,08130,488,56830,900,26724,654,31125,168,08427,864,80926,724,88426,645,82223,991,58628,449,27524,743,29622,853,29822,906,40732,250,26710,974,79111,884,00618,031,43413,470,033
       Accounts payable 
9,034,815
6,411,349
7,597,374
6,617,747
10,212,825
8,708,320
8,677,397
9,176,795
9,203,182
9,471,590
10,534,949
8,864,583
4,521,705
6,224,553
6,849,051
9,422,313
9,381,325
5,736,432
8,661,711
11,965,960
20,683,779
17,137,762
15,789,534
18,071,434
18,071,43415,789,53417,137,76220,683,77911,965,9608,661,7115,736,4329,381,3259,422,3136,849,0516,224,5534,521,7058,864,58310,534,9499,471,5909,203,1829,176,7958,677,3978,708,32010,212,8256,617,7477,597,3746,411,3499,034,815
       Other Current Liabilities 
4,435,218
11,620,085
4,286,632
4,357,044
700,822
809,724
847,327
13,127,409
17,311,809
12,007,551
13,722,064
15,067,534
21,138,836
16,189,711
15,230,872
16,891,551
19,105,913
16,036,968
17,170,839
17,125,691
18,948,051
1,261,933
1,268,559
2,611,273
2,611,2731,268,5591,261,93318,948,05117,125,69117,170,83916,036,96819,105,91316,891,55115,230,87216,189,71121,138,83615,067,53413,722,06412,007,55117,311,80913,127,409847,327809,724700,8224,357,0444,286,63211,620,0854,435,218
   > Long-term Liabilities 
0
0
0
0
4,572,984
5,753,118
5,399,141
5,680,364
5,014,854
5,191,185
5,682,030
6,232,496
5,991,848
5,768,211
5,570,140
5,062,919
3,621,336
2,746,600
2,821,215
3,695,956
3,934,564
3,798,384
4,127,550
2,991,402
2,991,4024,127,5503,798,3843,934,5643,695,9562,821,2152,746,6003,621,3365,062,9195,570,1405,768,2115,991,8486,232,4965,682,0305,191,1855,014,8545,680,3645,399,1415,753,1184,572,9840000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
529,235
1,801,523
1,669,948
1,560,817
1,482,064
1,646,742
1,525,777
2,189,808
2,078,880
1,965,137
1,855,102
1,720,946
468,587
392,510
296,571
249,940
291,895
614,329
547,583
632,025
632,025547,583614,329291,895249,940296,571392,510468,5871,720,9461,855,1021,965,1372,078,8802,189,8081,525,7771,646,7421,482,0641,560,8171,669,9481,801,523529,2350000
       Long-term Liabilities Other 
0
0
0
0
1,074,245
882,416
1,005,785
1,613,009
1,540,107
1,701,130
1,748,561
1,464,497
1,201,682
921,946
923,410
1,014,102
570,223
789,106
832,961
948,995
678,553
778,779
1,063,882
1
11,063,882778,779678,553948,995832,961789,106570,2231,014,102923,410921,9461,201,6821,464,4971,748,5611,701,1301,540,1071,613,0091,005,785882,4161,074,2450000
> Total Stockholder Equity
162,529,700
160,484,372
164,751,619
169,226,195
262,691,716
265,558,452
270,608,001
273,777,313
272,804,099
279,953,708
288,930,971
296,114,858
299,996,337
307,974,559
314,225,043
316,939,430
320,745,911
323,344,876
327,238,441
333,511,375
336,397,327
344,548,335
350,495,646
358,207,481
358,207,481350,495,646344,548,335336,397,327333,511,375327,238,441323,344,876320,745,911316,939,430314,225,043307,974,559299,996,337296,114,858288,930,971279,953,708272,804,099273,777,313270,608,001265,558,452262,691,716169,226,195164,751,619160,484,372162,529,700
   Common Stock
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
9,700,035
0
0
0
0009,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,0359,700,035
   Retained Earnings 
141,325,149
139,020,516
143,628,082
147,904,089
238,168,788
240,965,564
246,167,848
254,079,206
255,930,472
260,783,355
268,233,108
273,162,587
278,527,362
285,376,727
291,591,459
295,448,756
299,196,323
304,767,401
309,318,586
314,789,986
317,328,364
326,073,361
332,417,039
339,984,187
339,984,187332,417,039326,073,361317,328,364314,789,986309,318,586304,767,401299,196,323295,448,756291,591,459285,376,727278,527,362273,162,587268,233,108260,783,355255,930,472254,079,206246,167,848240,965,564238,168,788147,904,089143,628,082139,020,516141,325,149
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
38,794
298,098
-42,221
156,348
-1,492,848
-1,422,887
-1,575,623
-1,467,651
-4,292,131
-1,995,405
-467,896
1,786,513
303,217
1,432,075
1,467,826
324,916
383,830
7,896,809
-3,245,903
-2,126,109
0
-2,617,845
0
0
00-2,617,8450-2,126,109-3,245,9037,896,809383,830324,9161,467,8261,432,075303,2171,786,513-467,896-1,995,405-4,292,131-1,467,651-1,575,623-1,422,887-1,492,848156,348-42,221298,09838,794



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue230,393,579
Cost of Revenue-131,232,966
Gross Profit99,160,61399,160,613
 
Operating Income (+$)
Gross Profit99,160,613
Operating Expense-200,223,291
Operating Income30,170,288-101,062,678
 
Operating Expense (+$)
Research Development1,072,478
Selling General Administrative36,418,171
Selling And Marketing Expenses0
Operating Expense200,223,29137,490,649
 
Net Interest Income (+$)
Interest Income3,339,274
Interest Expense-22,656
Other Finance Cost-0
Net Interest Income3,316,618
 
Pretax Income (+$)
Operating Income30,170,288
Net Interest Income3,316,618
Other Non-Operating Income Expenses0
Income Before Tax (EBT)33,793,31230,170,288
EBIT - interestExpense = -22,656
29,774,322
29,796,978
Interest Expense22,656
Earnings Before Interest and Taxes (EBIT)033,815,968
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax33,793,312
Tax Provision-4,018,990
Net Income From Continuing Ops29,774,32229,774,322
Net Income29,774,322
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-3,316,618
 

Technical Analysis of Whanin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Whanin. The general trend of Whanin is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Whanin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Whanin Pharm.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 13,810 < 14,210 < 14,240.

The bearish price targets are: 13,000 > 12,410.

Tweet this
Whanin Pharm Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Whanin Pharm. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Whanin Pharm Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Whanin Pharm. The current macd is -223.5944717.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Whanin price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Whanin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Whanin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Whanin Pharm Daily Moving Average Convergence/Divergence (MACD) ChartWhanin Pharm Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Whanin Pharm. The current adx is 41.40.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Whanin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Whanin Pharm Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Whanin Pharm. The current sar is 13,999.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Whanin Pharm Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Whanin Pharm. The current rsi is 35.62. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Whanin Pharm Daily Relative Strength Index (RSI) ChartWhanin Pharm Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Whanin Pharm. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Whanin price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Whanin Pharm Daily Stochastic Oscillator ChartWhanin Pharm Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Whanin Pharm. The current cci is -83.39010288.

Whanin Pharm Daily Commodity Channel Index (CCI) ChartWhanin Pharm Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Whanin Pharm. The current cmo is -28.90955869.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Whanin Pharm Daily Chande Momentum Oscillator (CMO) ChartWhanin Pharm Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Whanin Pharm. The current willr is -70.33898305.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Whanin is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Whanin Pharm Daily Williams %R ChartWhanin Pharm Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Whanin Pharm.

Whanin Pharm Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Whanin Pharm. The current atr is 224.33.

Whanin Pharm Daily Average True Range (ATR) ChartWhanin Pharm Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Whanin Pharm. The current obv is -36,226.

Whanin Pharm Daily On-Balance Volume (OBV) ChartWhanin Pharm Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Whanin Pharm. The current mfi is 26.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Whanin Pharm Daily Money Flow Index (MFI) ChartWhanin Pharm Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Whanin Pharm.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Whanin Pharm Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Whanin Pharm based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.624
Ma 20Greater thanMa 5014,189.500
Ma 50Greater thanMa 10014,468.600
Ma 100Greater thanMa 20014,574.500
OpenGreater thanClose13,800.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Whanin with someone you think should read this too:
  • Are you bullish or bearish on Whanin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Whanin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Whanin Pharm

I send you an email if I find something interesting about Whanin Pharm.


Comments

How you think about this?

Leave a comment

Stay informed about Whanin Pharm.

Receive notifications about Whanin Pharm in your mailbox!